HK
Hiroyuki Kubo
About Hiroyuki Kubo
Data last updated:
Hiroyuki Kubo is a Director at Sparsha Pharma International Private Limited (since 2018). The company operates in Pharma. Sparsha Pharma International Private Limited reported revenue of ₹29.04 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sparsha Pharma International Private Limited U24232TG2007PTC052719 | Director | 26 Mar 2018 | 2007 | ₹29.04 Cr (FY 2025) | Active |
Board colleagues of Hiroyuki Kubo
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bobba Venkatadri | 02272890 | Sparsha Pharma International Private Limited | Director |
| Dange Veerapaneni | 02317960 | Sparsha Pharma International Private Limited | Managing Director |
| Hema Latha Devi Veerapaneni | 00225447 | Sparsha Pharma International Private Limited | Director |
| J Sainathan | Sparsha Pharma International Private Limited | Company Secretary | |
| Jayaraman Sainathan | Sparsha Pharma International Private Limited | Company Secretary | |
| Rajini Telaprolu | 10412207 | Sparsha Pharma International Private Limited | Director |
| Shosaku Murayama | 02408044 | Sparsha Pharma International Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hiroyuki Kubo
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hiroyuki Kubo
Hiroyuki Kubo currently holds 1 directorship: Sparsha Pharma International Private Limited (Director, since 26 Mar 2018, revenue ₹29.04 Cr (FY 2025)).
Hiroyuki Kubo was first appointed on 26 Mar 2018 as Director at Sparsha Pharma International Private Limited.
The current boards of Hiroyuki Kubo's companies include Bobba Venkatadri (Sparsha Pharma International Private Limited), Dange Veerapaneni (Sparsha Pharma International Private Limited), Hema Latha Devi Veerapaneni (Sparsha Pharma International Private Limited), J Sainathan (Sparsha Pharma International Private Limited), Jayaraman Sainathan (Sparsha Pharma International Private Limited), Rajini Telaprolu (Sparsha Pharma International Private Limited), among others.